CKD represents another systemic amplifier of PH-HFpEF, with elevated levels of fibroblast growth factor-23 (FGF-23), oxidative stress, and vascular calcification contributing to endothelial dysfunction and increased PVR [28,29]. Here, FGF23 is linked to endothelial dysfunction.